Literature DB >> 23151438

The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model.

Hau D Le1, Erica M Fallon, Brian T Kalish, Vincent E de Meijer, Jonathan A Meisel, Kathleen M Gura, Vania Nose, Amy H Pan, Bruce R Bistrian, Mark Puder.   

Abstract

OBJECTIVE: Essential fatty acids (EFA) are necessary for growth, development, and biological function, and must be acquired through the diet. While linoleic acid (LA) and alpha-linolenic acid (ALA) have been considered the true EFAs, we previously demonstrated that docosahexaenoic acid (DHA) and arachidonic acid (AA) taken together as the sole source of dietary fatty acids can prevent biochemical essential fatty acid deficiency (EFAD). This study evaluates the effect of varying dietary ratios of DHA:AA in the prevention and reversal of biochemical EFAD in a murine model.
METHODS: Using a murine model of EFAD, we provided mice with 2.1% of daily caloric intake in varying DHA:AA ratios (1:1, 5:1, 10:1, 20:1, 200:1, 100:0) for 19 days in association with a liquid high-carbohydrate fat-free diet to evaluate the effect on fatty acid profiles. In a second experiment, we evaluated the provision of varying DHA:AA ratios (20:1, 200:1, 100:0) on the reversal of biochemical EFAD.
RESULTS: Mice provided with DHA and AA had no evidence of biochemical EFAD, regardless of the ratio (1:1, 5:1, 10:1, 20:1, 200:1, 100:0) administered. Biochemical EFAD was reversed with DHA:AA ratios of 20:1, 200:1, and 100:0 following 3 and 5 weeks of dietary provision, although the 20:1 ratio was most effective in the reversal and stabilization of the triene:tetraene ratio.
CONCLUSION: Provision of DHA and AA, at 2.1% of daily caloric intake in varying ratios can prevent biochemical evidence of EFAD and hepatic steatosis over the short-term, with a ratio of 20:1 DHA:AA most effectively reversing EFAD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151438      PMCID: PMC3608741          DOI: 10.1016/j.metabol.2012.10.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  22 in total

1.  Essential fatty acid deficiency. II. In adult rats.

Authors:  E AAES-JORGENSEN; E E LEPPIK; H W HAYES; R T HOLMAN
Journal:  J Nutr       Date:  1958-10-10       Impact factor: 4.798

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Apparent in vivo retroconversion of dietary arachidonic to linoleic acid in essential fatty acid-deficient rats.

Authors:  H S Hansen; B Jensen; P von Wettstein-Knowles
Journal:  Biochim Biophys Acta       Date:  1986-09-12

4.  Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.

Authors:  Ian P J Alwayn; Kathleen Gura; Vânia Nosé; Blanca Zausche; Patrick Javid; Jennifer Garza; Jennifer Verbesey; Stephan Voss; Mario Ollero; Charlotte Andersson; Bruce Bistrian; Judah Folkman; Mark Puder
Journal:  Pediatr Res       Date:  2005-01-19       Impact factor: 3.756

5.  Role of arachidonic acid in the regulation of the inflammatory response in TNF-alpha-treated rats.

Authors:  P R Ling; P Boyce; B R Bistrian
Journal:  JPEN J Parenter Enteral Nutr       Date:  1998 Sep-Oct       Impact factor: 4.016

6.  Essential fatty acid deficiency induces fatty acid desaturase expression in rat epididymis, but not in testis.

Authors:  Thomas Saether; Thien N Tran; Helge Rootwelt; Hans J Grav; Bjørn O Christophersen; Trine B Haugen
Journal:  Reproduction       Date:  2007-02       Impact factor: 3.906

7.  Purified fish oil eliminating linoleic and alpha linolenic acid meets essential fatty acid requirements in rats.

Authors:  Pei-Ra Ling; Mark Puder; Bruce R Bistrian
Journal:  Metabolism       Date:  2012-04-16       Impact factor: 8.694

8.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

Review 9.  Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects.

Authors:  A P Simopoulos
Journal:  World Rev Nutr Diet       Date:  2003       Impact factor: 0.575

10.  Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linolenate.

Authors:  H S Hansen; B Jensen
Journal:  Biochim Biophys Acta       Date:  1985-05-17
View more
  11 in total

Review 1.  Redefining essential fatty acids in the era of novel intravenous lipid emulsions.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Gillian L Fell; Meredith A Baker; Kathleen M Gura; Bruce R Bistrian; Mark Puder
Journal:  Clin Nutr       Date:  2017-07-08       Impact factor: 7.324

2.  The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.

Authors:  Shandi Hiebler; Tomohiro Masuda; Joseph G Hacia; Ann B Moser; Phyllis L Faust; Anita Liu; Nivedita Chowdhury; Ning Huang; Amanda Lauer; Jean Bennett; Paul A Watkins; Donald J Zack; Nancy E Braverman; Gerald V Raymond; Steven J Steinberg
Journal:  Mol Genet Metab       Date:  2014-01-23       Impact factor: 4.797

Review 3.  Intravenous Lipid Emulsions in Parenteral Nutrition.

Authors:  Gillian L Fell; Prathima Nandivada; Kathleen M Gura; Mark Puder
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

Review 4.  Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Meredith A Baker; Gillian L Fell; Mark Puder; Kathleen M Gura
Journal:  Nutr Clin Pract       Date:  2016-08-16       Impact factor: 3.080

5.  Is there an optimal dose for dietary linoleic acid? Lessons from essential fatty acid deficiency supplementation and adipocyte functions in rats.

Authors:  Isabelle Harant-Farrugia; Jésus Garcia; Mari-Carmen Iglesias-Osma; Maria José Garcia-Barrado; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2014-02-01       Impact factor: 4.158

6.  Intravenous Fish Oil and Serum Fatty Acid Profiles in Pediatric Patients With Intestinal Failure-Associated Liver Disease.

Authors:  Margaret L Ong; Robert S Venick; Stephen B Shew; James C Y Dunn; Laurie Reyen; Tristan Grogan; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-03-22       Impact factor: 4.016

Review 7.  Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.

Authors:  Giuseppe Astarita; Alexandra C Kendall; Edward A Dennis; Anna Nicolaou
Journal:  Biochim Biophys Acta       Date:  2014-12-05

8.  Phenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers.

Authors:  Elizabeth P Newberry; Susan Kennedy; Yan Xie; Jianyang Luo; Hui Jiang; Daniel S Ory; Nicholas O Davidson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

9.  Ω-3 fatty acids prevent hepatic steatosis, independent of PPAR-α activity, in a murine model of parenteral nutrition-associated liver disease.

Authors:  Esther Prince; Farrah B Lazare; William R Treem; Jiliu Xu; Jahangir Iqbal; Xiaoyue Pan; Joby Josekutty; Meghan Walsh; Virginia Anderson; M Mahmood Hussain; Steven M Schwarz
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-06-11       Impact factor: 4.016

10.  Effects of dietary omega-3 fatty acids on bones of healthy mice.

Authors:  Lorenzo Anez-Bustillos; Eileen Cowan; Maria B Cubria; Juan C Villa-Camacho; Amin Mohamadi; Duy T Dao; Amy Pan; Gillian L Fell; Meredith A Baker; Prathima Nandivada; Ara Nazarian; Mark Puder
Journal:  Clin Nutr       Date:  2018-09-01       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.